Smartleaf Asset Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$112K Hold
1,231
﹤0.01% 1113
2026
Q1
$109K Buy
1,231
+37
+3% +$3.4K ﹤0.01% 1068
2025
Q4
$108K Sell
1,194
-40
-3% -$3.79K ﹤0.01% 1147
2025
Q3
$121K Buy
1,234
+482
+64% +$47.8K 0.01% 958
2025
Q2
$68.8K Buy
752
+15
+2% +$1.45K 0.01% 1023
2025
Q1
$82.7K Sell
737
-83
-10% -$8.88K 0.01% 915
2024
Q4
$86.4K Buy
820
+57
+7% +$6.12K 0.01% 907
2024
Q3
$82.6K Buy
763
+389
+104% +$42.5K 0.01% 767
2024
Q2
$40.5K Buy
374
+276
+282% +$32.5K 0.01% 804
2024
Q1
$13K Buy
98
+48
+96% +$6K ﹤0.01% 941
2023
Q4
$6.08K Buy
+50
New +$5.58K ﹤0.01% 832

Other funds holding ZBH

Smartleaf Asset Management's ZBH Position: Q2 2026 in Review

Smartleaf Asset Management held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 1,231 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #1113.

Smartleaf Asset Management first reported a position in ZBH in Q4 2023 and has held it in 11 quarters since. The position peaked at $121K in Q3 2025. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Smartleaf Asset Management held 1,231 shares of Zimmer Biomet worth $112K as of Q2 2026.
  • Smartleaf Asset Management left its Zimmer Biomet share count unchanged in Q2 2026.
  • Zimmer Biomet made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #1113 holding.
  • Smartleaf Asset Management first reported a position in Zimmer Biomet in Q4 2023 and has held it in 11 quarters since.
  • Smartleaf Asset Management's Zimmer Biomet position peaked at $121K in Q3 2025.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.